Options
Mg. Zuñiga-San Martin, Carlos
Research Outputs
Increasing access to integrated ESKD care as part of universal health coverage
2019, Harris, David C.H, Davies, Simon J., Finkelstein, Fredric O., Jha, Vivekanand, Donner, Jo-Ann, Abraham, Georgi, Bello, Aminu K., Caskey, Fergus J., Garcia Garcia, Guillermo, Harden, Paul, Hemmelgarn, Brenda, Johnson, David W., Levin, Nathan W., Luyckx, Valerie A., Martin, Dominique E., McCulloch, Mignon I., Moosa, Mohammed Rafique, O’Connell, Philip J., Okpechi, Ikechi G., Pecoits Filho, Roberto, Shah, Kamal D., Sola, Laura, Swanepoel, Charles, Tonelli, Marcello, Twahir, Ahmed, van Biesen, Wim, Varghese, Cherian, Yang, Chih-Wei, Zuñiga-San Martin, Carlos
The global nephrology community recognizes the need for a cohesive strategy to address the growing problem of end-stage kidney disease (ESKD). In March 2018, the International Society of Nephrology hosted a summit on integrated ESKD care, including 92 individuals from around the globe with diverse expertise and professional backgrounds. The attendees were from 41 countries, including 16 participants from 11 low- and lower-middle–income countries. The purpose was to develop a strategic plan to improve worldwide access to integrated ESKD care, by identifying and prioritizing key activities across 8 themes: (i) estimates of ESKD burden and treatment coverage, (ii) advocacy, (iii) education and training/workforce, (iv) financing/funding models, (v) ethics, (vi) dialysis, (vii) transplantation, and (viii) conservative care. Action plans with prioritized lists of goals, activities, and key deliverables, and an overarching performance framework were developed for each theme. Examples of these key deliverables include improved data availability, integration of core registry measures and analysis to inform development of health care policy; a framework for advocacy; improved and continued stakeholder engagement; improved workforce training; equitable, efficient, and cost-effective funding models; greater understanding and greater application of ethical principles in practice and policy; definition and application of standards for safe and sustainable dialysis treatment and a set of measurable quality parameters; and integration of dialysis, transplantation, and comprehensive conservative care as ESKD treatment options within the context of overall health priorities. Intended users of the action plans include clinicians, patients and their families, scientists, industry partners, government decision makers, and advocacy organizations. Implementation of this integrated and comprehensive plan is intended to improve quality and access to care and thereby reduce serious health-related suffering of adults and children affected by ESKD worldwide.
Challenges for sustainable end-stage kidney disease care in low-middle-income countries: The problem of the workforce
2020, Swanepoel, Charles R., McCulloch, Mignon I., Abraham, Georgi, Donner, Jo-Ann, Alrukhaimi, Mona N., Blake, Peter G., Bunnag, Sakarn, Claus, Stefaan, Dreyer, Gavin, Ghnaimat, Mohammad A., Ibhais, Fuad M., Liew, Adrian, McKnight, Marla, Yewondwossen Tadesse, Mengistu, Naicker, Saraladevi, Niang, Abdou, Obrador, Gregorio T., Perl, Jeffrey, Harun Ur, Rashid, Tonelli, Marcello, Tungsanga, Kriang, Vachharajani, Tushar, Zakharova, Elena, Zuñiga-San Martin, Carlos, Finkelstein, Fredric O.
Prevention and early detection of kidney diseases in adults and children should be a priority for any government health department. This is particularly pertinent in the low-middle-income countries, mostly in Asia, Africa, Latin America, and the Caribbean, where up to 7 million people die because of lack of end-stage kidney disease treatment. The nephrology workforce (nurses, technicians, and doctors) is limited in these countries and expanding the size and expertise of the workforce is essential to permit expansion of treatment for both chronic kidney disease and end-stage kidney disease. To achieve this will require sustained action and commitment from governments, academic medical centers, local nephrology societies, and the international nephrology community.